PARTNER: Psoriatic arthritis and other comorbidities in patients with psoriasis

PARTNER: Psoriatic arthritis and other comorbidities in patients with psoriasis

2 Category 2 points with the RACGP

1 Core PDP point

All participants will be awarded a certificate of completion for self-reporting to other colleges

In collaboration with GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis) and the Australasian College of Dermatologists
Proudly supported by Psoriasis Australia

This interactive e-module will take about 60 minutes to complete and includes:

  • Recorded audio from 2 patients with psoriasis and psoriatic arthritis
  • Tips and tools for screening and diagnosing psoriatic arthritis
  • Real patient stories (not just cases), from symptoms to treatment
  • Information on:
    • Common comorbidities in psoriasis – do you know the leading cause of death?
    • How to monitor patients who are on biologics

Learning objectives:
Upon completing this course, you will be able to:

  • Differentiate the outcomes for psoriatic arthritis patients who are diagnosed, referred and treated as early as symptoms are recognised
  • Be aware of the associated cardiovascular, metabolic and psychosocial comorbidities
  • Identify process changes needed in practice to recognise psoriatic arthritis symptoms early

Independent Medical Education
This programme was supported by an independent educational grant from Pfizer IGLC. Pfizer had no influence on the content or involvement in the development of the programme or the selection of faculty.

A/Prof Peter Nash
Department of Medicine, University of Queensland; Director, Rheumatology Research Unit, Sunshine Coast; member of the International Steering Committee for Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)

Dr Samantha Ranasinghe
Practising GP, Morningside General Practice Clinic and Belmont General Practice Clinic; Brisbane, Queensland, Australia

  • Royal Australian College of General Practitioners:
    • 2 Category Two QI&CPD points
    • Activity no. 163998
  • Australian College of Rural and Remote Medicine:
    • 1 Core PDP point
    • Activity no. 17325

  • Dr Nash has received grants for research and clinical trials and honoraria for advice and lectures from AbbVie, Amgen, Bristol–Myers Squibb, Eli Lilly, Janssen, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and UCB.

You are not enrolled in this course. Click the following button to take this course